It does look like $160 to $170 for AGN from the bearish charts, but can it really go that low. With the Italy election and what is going on with Euro, it might do it sooner than later. AGN in the US might be a buy with the Insider Buying + Low PE + Good potential on the low market cap relative to PFE, BMY and others. Of course, selling the Generics to Teva has brought in good amount of cash to pay off debt or buy something (GILD was ruled out). Maybe wait for 2019 LEAPS, or do a Feb Put Sell when it has a selloff soon.